Bio
Rumiana Tenchov is an information scientist at CAS. She earned her Ph.D. and D.Sc. degrees in biophysics from the Bulgarian Academy of Sciences. Prior to joining CAS, she was a research faculty member at the Department of Molecular Biosciences of the Northwestern University.
Emerging Science
Decoding neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
Drug Discovery
Are inverse vaccines the cure for autoimmune diseases?
Sharing new research on inverse vaccines, potential new breakthroughs in treating autoimmune diseases like multiple sclerosis, type 1 diabetes and celiac disease
Drug Discovery
Ending Alzheimer's: Emerging trends in biomarkers, gene therapy, and more
Biomarkers, personalized medicine and gene therapies are fueling research breakthroughs. Discover new treatments targeting genetics and protein buildup to manage this devastating disease.
Drug Discovery
Can we cure Huntington's? Research trends in PolyQ and rare diseases
While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.
Biotechnology
How biomarkers unlock faster cancer detection, improving outcomes
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
Emerging Science
Biomarkers: The key to earlier cancer detection and patient outcomes
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
Emerging Science
重新想象衰老：探索抗衰老治疗策略的潜力
探索最新的抗衰老治疗策略，促进健康和长寿。 在我们的最新文章中了解干细胞疗法、透明质酸、抗衰老药物和基因疗法的最新研究，以及当前正在进行临床试验的管线分析。
Emerging Science
聚乙二醇化脂质纳米颗粒的终极指南
了解如何克服 PEG 免疫原性对聚乙二醇化脂质纳米颗粒药物递送安全性和有效性的影响这一挑战。 本文综述了目前解决 PEG 免疫原性的最新研究进展，从阐明抗 PEG 抗体生成的影响因素到开发新型药物载体或优化给药和剂量。
Emerging Science
是友非敌：肠道微生物组利于改善健康
肠道微生物组是一个由数万亿细菌组成的复杂生态系统，这些细菌存活在我们的消化道中，具有提供免疫力、改善心理健康和提供治疗选择等健康益处。 近年来，人们对微生物组疗法治疗各种疾病的潜力越来越感兴趣。 随着我们对肠道微生物组的理解不断加深，我们有望在未来几年看到微生物组疗法的更多进展。
Biotechnology
不断发展的外泌体：从无名小卒到后起之秀
A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.
Safety
硝酸铵：提高产品安全，降低未来风险
硝酸铵有能力养活数十亿人，但如果储存不当，就像一枚等待发生的炸弹。我们怎样才能使这种肥料更安全？了解新兴科学、更安全的替代方案以及安全储存和运输的最佳实践。
Drug Discovery
纳米技术除 COVID-19 之外的治疗潜力
了解更多关于脂质纳米颗粒的内容：起源、在 COVID 疫苗中的角色和未来应用。 本文概述了在疫苗、药物递送和非治疗应用（如农业化学、化妆品和食品科学）方面的出版物、里程碑意义事件和未来应用的新兴趋势与洞察。
Drug Discovery
新冠病毒变异株不断更迭，口罩技术如何创新？
COVID大流行暴露了口罩开发和生产方面的缺陷。创新对于减缓病毒新变种的传播至关重要。口罩有许多因素可以改进，本文重点关注改善过滤和微生物去除的新兴科学。
Emerging Science
肠道微生物组与抑郁和焦虑有何关联
肠道微生物群、肠道菌群或微生物组是生活在人类和其他动物消化道中的微生物。 虽然有些细菌与疾病相关，但另一些细菌对健康的许多方面都尤为重要。
Biotechnology
脂质纳米颗粒：癌症治疗的重要参与者
Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.
